Market Tracker

02/12 5:16pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.7879
Delayed Data
As of Feb 12
 +0.0279 / +3.67%
Today’s Change
0.74
Today|||52-Week Range
2.35
-22.75%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close0.76
Today’s open0.80
Day’s range0.75 - 0.82
Volume62,622
Average volume (3 months)451,866
Market cap$75.8M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)+256.25%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...+0.02+0.89%
PTIEPain Therapeutics In...+0.02+1.13%
GNCAGenocea Biosciences ...+0.65+21.59%
TENXTenax Therapeutics I...+0.02+0.85%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts